ADCYAP1R1 and migraine disorder: Further, it remains to be established whether the same patients that show a positive therapeutic response to CGRP (receptor)-antibodies will have a positive response to PAC1 antibodies, or that both types of medications are most effective in a separate population of migraine patients, depending on the peptide that is most predominant in their individual migraine pathophysiology.